Knight Therapeutics is a specialty pharmaceutical company based in Montreal, Canada. It acquires, licenses and commercializes prescription medicines, building a portfolio of products that it markets in Canada and in selected Latin American countries. Its medicines address areas such as cancer care, infectious disease and skin conditions, and its customers are mainly physicians, hospitals and pharmacies that use or dispense prescription treatments. The company also provides related services to partners seeking to bring their products into these markets.
On this site Knight Therapeutics Inc. appears as a stock on the Toronto Exchange (Canada), code GUD, with prices in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #5 of 870 on the Toronto Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Canada yet.
TrendStrong
97/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average40.0%
From 52-week high0.0%
MomentumStrong
91/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return20.9%
6-month return57.5%
12-month, skipping last month77.4%
Stability (higher is calmer)Strong
86/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)26.5%
Worst drawdown, 1 year (smaller is calmer)-8.5%
LiquidityFair
51/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.84M CAD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Canada when fundamentals data for this market is added. All Canada stocks.
52-wk range 5.66 – 11.83Daily closes, split-adjusted
Signals
50-day average10.18
200-day average8.36
Golden/death cross (60d)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)0.28
Technical summary
Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
11.09
Bullish
EMA 10
11.18
Bullish
SMA 20
10.75
Bullish
EMA 20
10.85
Bullish
SMA 50
10.18
Bullish
EMA 50
10.34
Bullish
SMA 100
9.84
Bullish
EMA 100
9.73
Bullish
SMA 200
8.36
Bullish
EMA 200
8.78
Bullish
Oscillators (daily)
RSI (14)
77.87
Bearish
MACD (12, 26)
0.38
Bullish
Momentum (12)
12.93
Bullish
Stochastic %K (14)
91.98
Bearish
Williams %R (14)
-8.02
Bearish
CCI (20)
191.0
Bearish
Pivot points (classic, last session)
S3
11.28
S2
11.41
S1
11.56
Pivot
11.69
R1
11.84
R2
11.97
R3
12.12
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CAD. Educational only, not financial advice.
